Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Long-term Treatment Evaluation of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy

NCT00293020 is registered in ClinicalTrials.gov with BioDelivery Sciences International as lead sponsor.

NCT NCT00293020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00293020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Long-term Treatment Evaluation of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy
Lead sponsor
BioDelivery Sciences International
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
June 30, 2008
Enrollment
244 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, pain